-
2025
09 Certification of Korea Manufacturing and
Quality System (KGMP) for medical device07 Summative usability testing for PINE SPEECH05 Selected for DTx development and
demonstraton project sponsoed by
the Ministry of Science and ICT (funding KRW 1 bln.)04 First-In-Class, PD speech-language digital therapeutics,
PINE SPEECH® v1.0 released -
2024
12 Establishment of corporate research institute11 Venture company certification
by the Ministry of SMEs and Startups10 Selected for Deeptech TIPS project sponsored by
the Ministry of SMEs and Startups (funding KRW 1.5 bln.)08 Seed funding round -
Medytox Venture Investment, HG Initiative06 PINE digital health incorporated -
2023
Q4 Feasibility testing for elderly 25 PD patients in
Seoul National University HospitalQ3 Development of MVP for PD speech-language treatment -
2022
Q3 Preliminary clinical study on
PD speech-language remote treatment
Why Parkinson's
We believe in clinical evidence, we provide reliable treatments, we use safe technology.
I'm PINE, are you fine?
Parkinson's disease(PD) is currently the fastest-growing neurodegenerative disease in the world, characterized by a range of motor and non-motor symptoms, still without a cure. It typically begins between the ages of 55 and 65, affecting about 1-1.5% of the population over 65 worldwide. In Korea, approximately 150 thousand individuals are affected, and globally, the number exceeds 10 million.
Non-pharmacological treatments for PD are as necessary as pharmacological treatments but are currently not sufficiently provided. This is because there are not enough medical institutions that offer proper non-pharmacological treatments, most patients have mobility challenges to visit hospital, and there is the cost issue for in-person treatment.
